InvestorsHub Logo
Followers 31
Posts 1644
Boards Moderated 0
Alias Born 03/09/2011

Re: JRoon71 post# 404995

Monday, 03/06/2023 4:51:11 PM

Monday, March 06, 2023 4:51:11 PM

Post# of 430271
And unfortunately Sarissa's understanding of EU reimbursement and role out experience are minimal.

Unless they already have a buyer in mind this could be a disaster.

I was concerned during the proxy fight that Sarissa's legal firm could not even successfully put together their proxy without Amarin assisting them along the way and directing them on what the UK laws were.

Pharmacydude pretty much spelled this out to all of us with a post about a month ago on what was going to happen and how value of the stock would behave. It looks like he was spot on so far and we will see if the major institutions jump ship with way too much risk currently. My thoughts are that we will continue to have a sell off.

I've got to decide now whether the risks outweigh the benefits. For now I'm staying on board but I anticipate a substantial decrease in share price over the next several weeks to months and not purchasing any more shares d/t risk/benefit.

Just my opinion and disappointed that it has come to this with such a valuable asset.

Right now SP is unchanged AH so that is a positive however.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News